Byrd, J C

Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53. [electronic resource] - Blood Nov 1998 - 3804-16 p. digital

Publication Type: Journal Article

0006-4971


Animals
Antineoplastic Agents--administration & dosage
Apoptosis--drug effects
Caspase 3
Caspases--physiology
Cell Cycle Proteins
Chromosomes, Human, Pair 17--genetics
Cyclin-Dependent Kinase Inhibitor p27
Drug Administration Schedule
Drug Resistance, Neoplasm
Drug Screening Assays, Antitumor
Enzyme Activation--drug effects
Enzyme Precursors--metabolism
Flavonoids--administration & dosage
Gene Deletion
Genes, p53
Growth Inhibitors--administration & dosage
Humans
In Situ Hybridization, Fluorescence
Interleukin-4--pharmacology
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Mice
Mice, Inbred C57BL
Mice, Knockout
Microtubule-Associated Proteins--biosynthesis
Neoplasm Proteins--biosynthesis
Piperidines--administration & dosage
Proto-Oncogene Proteins--biosynthesis
Proto-Oncogene Proteins c-bcl-2--biosynthesis
Tumor Cells, Cultured
Tumor Suppressor Protein p53--physiology
Tumor Suppressor Proteins
Vidarabine--analogs & derivatives
bcl-2-Associated X Protein